BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis.

已完结 10 由 OM 发布于 2025/12/22 15:32:42

DOI:10.1016/j.ard.2025.06.2128
作者：Ziwei Hu, Shaozhe Cai, Yikai Yu, Yu Chen, Bei Wang, Di Wang, Rui Zeng, Xiaofeng He, Guifen Shen, Fei Yu, Zhipeng Zeng, Yuxue Chen, Xiaofang
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Objectives: This study aims to evaluate the safety and efficacy of anti-B cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T cells in treating refractory lupus nephri

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierImplementation of machine learning tool for continued process verification of process chromatography unit operation